This is the authors' abstract. We don't add key points for this paper.
A new heterocyclic framework of 2-(4-{[(2-oxo-2H-chromen-4-yl)oxy]methyl}-1H-1,2,3-triazol-1-yl)-N-[4-(3-oxomorpholino)phenyl]acetamide was constructed using the copper-catalyzed click chemistry tool as a key reaction. The synthesized compounds were subjected to in vitro antimicrobial activity against gram-positive (S. aureus, S. pyogenes), gram-negative (E. coli, P. aeruginosa), and fungal strains (C. albicans, A. clavatus, and A. niger) concerning standard drugs. The screened compounds show moderate to good activity against various bacteria and fungi. The compounds were also studied for in silico molecular docking with the target protein of bacteria and fungi to investigate potential inhibition properties. The study suggests that compounds some have the potential and, after other detailed studies, may be useful for medicinal purposes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mahida et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: